Deflazacort: استعمال، خوراک، ضمني اثرات ۽ وڌيڪ
تعارف: ڊيفلازاڪارٽ ڇا آهي؟
If you or a loved one are managing an autoimmune disease, inflammatory disorder, or a specific type of cancer, your doctor may have prescribed Deflazacort. This corticosteroid medication is primarily used to reduce inflammation and suppress the immune system.
It is similar to other corticosteroids but is known for a lower risk of certain side effects, particularly bone mineral density loss and weight gain, making it a valuable option for various conditions, including Duchenne muscular dystrophy.
اشارو ۽ استعمال
FDA-Approved Indication
Deflazacort (brand name: Emflaza) is FDA-approved for the treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and older.
DMD is a rare, inherited muscle disease characterised by progressive muscle degeneration and weakness, caused by an absence of the protein dystrophin.
Deflazacort is the only corticosteroid with a specific FDA approval for DMD.
Off-Label Use in India
In Indian clinical practice, deflazacort is widely prescribed off-label as a corticosteroid for various inflammatory and autoimmune conditions. These uses are based on clinical experience and regional prescribing patterns; they are not FDA-approved indications.
Common off-label uses include:
- خودڪار مدافعتي خرابيون: Rheumatoid arthritis, systemic lupus erythematosus (SLE), autoimmune hepatitis
- سوزش جون حالتون: Asthma, inflammatory bowel disease (IBD), nephrotic syndrome
- الرجڪ حالتون: Severe allergic reactions, allergic rhinitis (in moderate to severe cases only)
- Dermatological conditions: Severe eczema, pemphigus, and other autoimmune skin disorders
- Organ transplant: As part of immunosuppressive regimens to prevent graft rejection
- ڪجهه ڪينسر: As part of treatment regimens for specific haematological malignancies, including leukaemia and lymphoma
Deflazacort is not recommended for mild allergies or conditions that can be managed with non-steroidal anti-inflammatory drugs. It should be used only when the clinical situation warrants corticosteroid therapy, as determined by the prescribing physician.
ڪيئن اهو ڪم
Deflazacort works by mimicking the effects of hormones produced by the adrenal glands, particularly cortisol.
اهو جسم ۾ انهن مادن جي ڇڏڻ کي روڪي سوزش کي گهٽائي ٿو جيڪي سوزش ۽ مدافعتي ردعمل جو سبب بڻجن ٿا.
آسان لفظن ۾، اهو مدافعتي نظام کي پرسکون ڪري ٿو ۽ مختلف حالتن سان لاڳاپيل سوجن، لالچ ۽ درد کي گهٽائي ٿو.
After oral administration, deflazacort is rapidly converted to its active metabolite, 21-desacetyldeflazacort, which is responsible for its therapeutic effects.
ڌنڌو
DMD Dosing (FDA-Approved)
- Adults and children aged 2 years and older: 0.9 mg/kg/day, administered once daily
- Available formulations: Tablets (6 mg, 18 mg, 30 mg, 36 mg) and oral suspension (22.75 mg/mL)
- If using tablets, round up to the nearest possible dose; any combination of tablet strengths may be used to achieve the calculated dose
- If using oral suspension, round up to the nearest tenth of a millilitre (mL)
Off-Label Dosing (India)
For off-label inflammatory and autoimmune indications, the typical adult dose ranges from 6 to 48 mg/day, depending on the condition, severity, and clinical response.
The dose is usually started at a higher level and tapered gradually to the lowest effective maintenance dose.
Dosing should always be individualised under medical supervision.
For children (off-label), the dosage is typically based on body weight, ranging from 0.5 to 1.5 mg/kg/day depending on the condition and severity.
Take deflazacort with or without food. Swallow the tablet whole.
Follow your healthcare provider’s instructions strictly.
If a dose is missed, take it as soon as you remember. If it’s close to the time for your next dose, skip the missed dose and resume your regular schedule. Do not double the dose to make up for the missed one.
اهم حفاظت جي ڄاڻ
خبردار: Read this section carefully before taking deflazacort.
Adrenal suppression: Deflazacort, like all corticosteroids, causes suppression of the hypothalamic-pituitary-adrenal (HPA) axis with long-term use.
Do not stop deflazacort abruptly. Doses must be tapered gradually under medical supervision.
Abrupt discontinuation after prolonged use can cause adrenal crisis, a potentially life-threatening condition characterised by severe fatigue, weakness, low blood pressure, nausea, and confusion.
Long-term use of deflazacort increases the risk of:
- Osteoporosis and fractures (particularly vertebral and hip fractures)
- Cataracts and glaucoma (increased intraocular pressure)
- Hyperglycaemia and new-onset diabetes mellitus
- Immunosuppression and increased susceptibility to infections (including opportunistic infections such as Pneumocystis jirovecii pneumonia and strongyloides)
- Cushingoid features (moon face, truncal obesity, buffalo hump, striae, easy bruising)
- Growth retardation in children (monitor growth regularly in paediatric patients)
- Avascular necrosis of bone (particularly the femoral head)
- Psychiatric effects: mood changes, insomnia, psychosis (especially at high doses)
- Peptic ulceration (risk increased when used with NSAIDs)
Paediatric patients on long-term deflazacort for DMD require regular monitoring of growth (height and weight), bone mineral density (DEXA scans), blood glucose levels, ophthalmological examinations (for cataracts and glaucoma), and adrenal function.
پيدائش: There are no adequate and well-controlled studies of deflazacort in pregnant women. Corticosteroids have been shown to be teratogenic in animal studies.
Deflazacort should be used during pregnancy only if the potential benefit justifies the potential risk to the foetus.
Infants born to mothers who received corticosteroids during pregnancy should be monitored for signs of adrenal insufficiency.
کير پيارڻ: Corticosteroids are excreted in human milk. Use with caution in breastfeeding women and consider the benefits of breastfeeding alongside the risks.
لائيو ويڪسين: Live-attenuated and live vaccines are contraindicated during immunosuppressive doses of deflazacort.
All immunisations should be administered according to guidelines prior to starting deflazacort. Live vaccines should be given at least 4 to 6 weeks before starting therapy.
ڊيفلازاڪارٽ جا ضمني اثرات
While Deflazacort can be effective, it may also cause side effects.
عام ضمني اثرات
- وزن ۾ اضافو
- وڌيل تڪليف
- مزاج ۾ تبديليون (مثال طور، پريشاني، ڊپريشن)
- اندرا
- هاء بلڊ شگر جي سطح
سخت طرفون اثرات
- انفيڪشن جي خطري ۾ اضافو
- هڏن جو پتلو ٿيڻ (اوستيوپورسس)
- معدي جا مسئلا (مثال طور، السر)
- اکين جا مسئلا (مثال طور، موتيا بند، گلوڪوما)
- ايڊينل دٻاءُ (جسم جي قدرتي اسٽيرائيڊ پيدا ڪرڻ جي ناڪامي)
دوا جي مداخلت
ڊيفلازاڪارٽ ڪيترن ئي دوائن ۽ مادن سان رابطو ڪري سگھي ٿو، جن ۾ شامل آهن:
- CYP3A4 روڪيندڙ: Strong CYP3A4 inhibitors (such as ketoconazole, itraconazole, clarithromycin, and ritonavir) can increase deflazacort levels. If co-administration cannot be avoided, the deflazacort dose should be reduced to one-third of the recommended dose.
- CYP3A4 inducers: Drugs such as rifampicin, carbamazepine, phenytoin, and phenobarbital can reduce deflazacort levels, potentially decreasing its effectiveness.
- اينٽي ڪوگولنٽ: جهڙوڪ وارفرين، جنهن جا اثر تبديل ٿي سگهن ٿا.
- ذيابيطس جي خلاف دوائون: رت ۾ شگر جي سطح وڌڻ جي ڪري ترتيب ڏيڻ جي ضرورت پئجي سگھي ٿي.
- غير اسٽيرائڊل ضد سوزش واري دوا (NSAIDs): معدي جي رت وهڻ جو خطرو وڌي ٿو.
- ويڪسين: Live-attenuated vaccines are contraindicated. Killed or inactivated vaccines may have reduced immunological response during corticosteroid therapy.
ممڪن رابطي کان بچڻ لاءِ هميشه پنهنجي صحت جي سار سنڀار فراهم ڪندڙ کي انهن سڀني دوائن ۽ سپليمنٽس بابت آگاهه ڪريو جيڪي توهان وٺي رهيا آهيو.
Deflazacort جا فائدا
Despite the risks associated with long-term corticosteroid use, deflazacort offers several benefits when used appropriately:
- ڊي ايم ڊي In Duchenne muscular dystrophy, deflazacort has been shown to prolong ambulation (ability to walk), slow the decline of muscle strength, reduce the risk of scoliosis, and delay the onset of cardiomyopathy and respiratory decline.
- Comparatively bone-sparing: Compared with other corticosteroids such as prednisone, deflazacort has been associated with a lower impact on bone mineral density, making it a preferred choice when long-term corticosteroid therapy is required.
- Anti-inflammatory efficacy: Effective in reducing inflammation and immune-mediated tissue damage in a range of autoimmune and inflammatory conditions.
- Immunosuppression: Useful in managing conditions where suppression of the immune system is required, including organ transplant recipients.
ڊيفلازاڪورٽ جا تضاد
ڪجهه ماڻهن کي ڊيفلازاڪارٽ استعمال ڪرڻ کان پاسو ڪرڻ گهرجي، جنهن ۾ شامل آهن:
- حامله عورتون: اهو جنين کي نقصان پهچائي سگھي ٿو. ان جي استعمال تي احتياط سان غور ڪيو وڃي، ۽ جيڪڏهن حمل ممڪن هجي ته علاج شروع ڪرڻ کان اڳ حمل جي ٽيسٽ جي ضرورت پئجي سگھي ٿي.
- فعال انفيڪشن وارا فرد: اهو مدافعتي نظام کي دٻائي سگهي ٿو، جنهن سان انفيڪشن جي خراب ٿيڻ يا پکڙجڻ جو خطرو وڌي ٿو.
- ڪجهه صحت جي حالتن سان مريض: جيئن ته سخت جگر جي بيماري، فعال پيپٽڪ السر، يا بي قابو ذیابيطس.
هميشه صحت جي سار سنڀار فراهم ڪندڙ سان صلاح ڪريو ته اهو طئي ڪيو وڃي ته ڇا ڊيفلازاڪارٽ توهان جي صورتحال لاءِ مناسب آهي.
احتياط ۽ خبردار
ڊيفلازاڪارٽ شروع ڪرڻ کان اڳ، هيٺ ڏنل احتياطي تدبيرن تي غور ڪريو:
- باقاعده نگراني: مريضن کي رت جي شگر جي سطح، جگر جي ڪم، ۽ ٻين معيارن جي نگراني لاءِ باقاعده رت جي ٽيسٽن جي ضرورت پئجي سگھي ٿي.
- بتدريج بندش: جيڪڏهن توهان ڊگهي عرصي کان ڊيفلازاڪارٽ تي آهيو، ته پوءِ دوا جي واپسي جي علامتن کان بچڻ لاءِ دوا جي مقدار کي بتدريج گهٽائڻ تمام ضروري آهي.
- ويڪسينشن: پنهنجي صحت جي سار سنڀار فراهم ڪندڙ سان ويڪسينيشن منصوبن تي بحث ڪريو، خاص طور تي زنده ويڪسين جي حوالي سان.
- انفيڪشن جو خطرو: انفيڪشن جي ڪنهن به نشاني (بخار، ڳلي ۾ سور، وڌيل درد) لاءِ هوشيار رهو، ۽ انهن کي فوري طور تي پنهنجي ڊاڪٽر کي رپورٽ ڪريو، ڇاڪاڻ ته توهان جو مدافعتي نظام دٻجي سگهي ٿو.
وچين سوالن جا جواب
ڊيفلازاڪارٽ ڇا لاءِ استعمال ٿيندو آهي؟
Deflazacort is FDA-approved for the treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and older. In India, it is also widely used off-label for autoimmune and inflammatory conditions such as rheumatoid arthritis, asthma, nephrotic syndrome, and severe allergic conditions.
What is the correct dose for DMD?
The FDA-approved dose for DMD is 0.9 mg/kg/day, administered once daily. The dose is based on the patient’s body weight and should be calculated by the prescribing physician.
مون کي ڊيفلازاڪارٽ ڪيئن وٺڻ گهرجي؟
اهو عام طور تي زباني طور تي ٽيبليٽ جي صورت ۾ ورتو ويندو آهي يا انجيڪشن ذريعي ڏنو ويندو آهي، جيئن توهان جي صحت جي سار سنڀار ڪندڙ جي هدايت مطابق.
عام ضمني اثرات ڇا آهن؟
عام ضمني اثرات ۾ وزن وڌڻ، بک ۾ واڌ، موڊ ۾ تبديليون، ۽ بي خوابي شامل آهن.
Can I stop deflazacort suddenly?
No. Deflazacort must not be stopped abruptly after prolonged use. Doses should be tapered gradually under medical supervision to avoid adrenal crisis.
جيڪڏهن مان حاملہ آهيان ته ڇا مان ڊيفلازاڪارٽ وٺي سگهان ٿي؟
Deflazacort should be used during pregnancy only if the potential benefit justifies the risk to the foetus. There are no adequate human studies. Discuss with your doctor.
Can I receive vaccines while on deflazacort?
Live vaccines are contraindicated during immunosuppressive doses. Killed or inactivated vaccines may be given but may have a reduced response. All vaccinations should ideally be completed before starting deflazacort.
Is deflazacort the same as prednisolone?
No. While both are corticosteroids, deflazacort is a distinct drug with a different pharmacological profile.
Studies suggest deflazacort may have a comparatively lower impact on bone mineral density and weight gain than prednisone/prednisolone, which is one reason it is preferred for long-term use in DMD.
ڊيفلازاڪارٽ ڪيئن ڪم ڪندو آهي؟
اهو سوزش کي گهٽائڻ ۽ مدافعتي ردعمل کي دٻائڻ لاءِ قدرتي هارمونز جي نقل ڪري ٿو.
ڇا ڪو سنجيده ضمني اثرات آهن؟
ها، سنگين ضمني اثرات ۾ انفيڪشن، اوستيوپورسس، ۽ معدي جي مسئلن جو وڌندڙ خطرو شامل ٿي سگھي ٿو.
ڇا مان اوچتو ڊيفلازاڪورٽ وٺڻ بند ڪري سگهان ٿو؟
نه، دوا واپس وٺڻ جي علامتن کان بچڻ لاءِ طبي نگراني هيٺ بتدريج دوا جي مقدار کي گهٽ ڪرڻ ضروري آهي.
مون کي ڇا ڪرڻ گهرجي جيڪڏهن مون کي هڪ دوز وڃايو؟
ياد اچڻ سان ئي وڃايل خوراک وٺو، پر جيڪڏهن توهان جي ايندڙ خوراک جو وقت ويجهو اچي ويو آهي ته ان کي ڇڏي ڏيو. ٻيڻو نه ڪريو.
ڇا ڊيفلازاڪارٽ ٻين دوائن سان رابطو ڪري سگھي ٿو؟
ها، اهو اينٽي ڪوگولنٽ، اينٽي ذيابيطس دوائن، ۽ NSAIDs، ٻين سان رابطو ڪري سگهي ٿو.
مان ڪيتري وقت تائين ڊيفلازاڪارٽ وٺي سگهان ٿو؟
علاج جو عرصو علاج هيٺ حالت جي لحاظ کان مختلف هوندو آهي. بهترين نتيجي لاءِ پنهنجي ڊاڪٽر جي صلاح تي عمل ڪريو.
Does deflazacort affect blood sugar levels?
Yes. Deflazacort can cause hyperglycaemia (elevated blood sugar) and may unmask latent diabetes or worsen existing diabetes.
Blood glucose levels should be monitored regularly, particularly during long-term use.
Should children on deflazacort for DMD be monitored differently?
Yes. Paediatric patients on long-term deflazacort for DMD require regular monitoring of growth, bone mineral density, blood glucose, ophthalmological examinations, and adrenal function.
Your child’s doctor will schedule these assessments.
برانڊ جا نالا
ڊيفلازاڪارٽ ڪيترن ئي برانڊ نالن سان مارڪيٽ ڪئي ويندي آهي، جنهن ۾ شامل آهن:
- ايمفلازا
- Deflazacort
- ڊيفلازاڪارٽ سينڊوز
ٿڪل
Deflazacort is a versatile corticosteroid medication that plays a crucial role in managing various inflammatory and autoimmune conditions.
جڏهن ته اهو اهم فائدا پيش ڪري ٿو، جنهن ۾ ٻين ڪارٽيڪوسٽرائڊس جي مقابلي ۾ ڪجهه ضمني اثرات جو گهٽ خطرو شامل آهي، اهو ضروري آهي ته سڀني امڪاني ضمني اثرات ۽ دوا جي رابطي کان واقف هجي.
هميشه پنهنجي صحت جي سار سنڀار فراهم ڪندڙ سان صلاح ڪريو ته جيئن توهان جي ضرورتن مطابق بهترين علاج جو منصوبو طئي ڪيو وڃي، ۽ ڪنهن به نئين يا خراب ٿيندڙ علامتن بابت کليل رابطي کي برقرار رکو، خاص طور تي ڊگهي مدت جي استعمال دوران يا خوراک کي ترتيب ڏيڻ وقت.
چنائي ۾ منهنجي ويجهو بهترين اسپتال
